Generation of three myotonic dystrophy type 1 patient iPSC lines (CBRCULi018-A, CBRCULi019-A, CBRCULi020-A) derived from lymphoblastoid cell lines for disease modelling and therapeutic research
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal title
Stem Cell ResearchDate Published
2024-04Publication Volume
76Publication Begin page
103375
Metadata
Show full item recordAbstract
Myotonic dystrophy type 1 (DM1) is the most prevalent adult-onset muscular dystrophy affecting 1 in 8,000 individuals. It is characterized by multisystemic symptoms, primarily myopathy. The root cause of DM1 is a heterozygous CTG triplet expansion beyond the normal size threshold in the non-coding region of the DM1 protein kinase gene (DMPK). In our study, we generated and characterized three distinct DM1 induced pluripotent stem cell (iPSC) lines with CTG repeat expansions ranging from 900 to 2000 in the DMPK gene. These iPSC lines maintained normal karyotypes, exhibited distinctive colony morphology, robustly expressed pluripotency markers, differentiated into the three primary germ layers, and lacked residual viral vectors.Citation
Pierre M, Jauvin D, Puymirat J, Boutjdir M, Chahine M. Generation of three myotonic dystrophy type 1 patient iPSC lines (CBRCULi018-A, CBRCULi019-A, CBRCULi020-A) derived from lymphoblastoid cell lines for disease modelling and therapeutic research. Stem Cell Res. 2024 Apr;76:103375. doi: 10.1016/j.scr.2024.103375. Epub 2024 Mar 3. PMID: 38490135.DOI
10.1016/j.scr.2024.103375ae974a485f413a2113503eed53cd6c53
10.1016/j.scr.2024.103375
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A).
- Authors: Chahine M, Jauvin D, Pierre M, Puymirat J, Boutjdir M
- Issue date: 2023 Sep
- Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.
- Authors: Jauvin D, Pierre M, Boutjdir M, Puymirat J, Chahine M
- Issue date: 2023 Mar
- Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)(200) expansion in the DMPK gene: CHUQi001-A.
- Authors: Martineau L, Racine V, Benichou SA, Puymirat J
- Issue date: 2018 Jan
- Generation of induced pluripotent stem cell lines from pediatric patients with congenital myotonic dystrophy (CBRCULi012-A and CBRCULi013-A) and age-matched controls (CBRCULi010-A and CBRCULi011-A).
- Authors: De Serres-Bérard T, Jauvin D, Puymirat J, Chahine M
- Issue date: 2023 Oct
- Generation of induced pluripotent stem cell line (ZZUi015-A) from a DM1 patient with cataract.
- Authors: Li T, Sun H, Wang Z, Zhang Q, Chen N, Zhang K, Wang Y, Xu Y
- Issue date: 2022 Jan